abstract |
Antibodies and humanized variants thereof, and antigen-binding fragments thereof, and other molecules capable of immunospecifically binding to the B7-H7 counter-receptor, H7CR, are provided, and their use in enhancing immune responses and in the treatment and diagnosis of cancer and other use in disease. |